Kronos Bio Inc. (NASDAQ: KRON) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT KRONOS BIO INC.

Kronos Bio Inc. (NASDAQ: KRON)
Listen to this Section


$1.00
+0.0062 ( +0.71% ) 27.0K

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.

Market Data


Open $1.00
Previous Close $0.99
Volume 27.0K
Market Cap $59.74M
Day Range $0.95 - $1.04
52 Week Range $0.69 - $1.60
Shares Outstanding 60.34M
Change % +0.71%
Net Change ▲ 0.0062
Insider Ownership -0.01%
Exchange NASDAQ
Sector Healthcare
Industry Medicinal Chemicals and Botanical Products
IPO Year 2020
Country United States
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 2,387,546.00

Date Type Amount Purchased Purchaser
2024-07-01 Buy 410848.00 BISCHOFBERGER NORBERT W
2024-06-26 Sale -34000.00 Yang Taiyin
2024-06-26 Sale -34000.00 TANEN DAVID M
2024-06-26 Sale -34000.00 Belldegrun Arie
2024-06-26 Sale -34000.00 Kazam Joshua A
2024-06-26 Sale -34000.00 Blunt Roshawn A.
2024-06-26 Sale -34000.00 Stultz Katherine V
2024-06-26 Sale -34000.00 DANSEY ROGER D
2024-06-26 Sale -11333.00 Ridloff Elena
2024-06-12 Buy 1378901.00 BISCHOFBERGER NORBERT W

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 Dec 27, 2024
8-k 8K-related 13 Nov 27, 2024
effect Other 1 Nov 14, 2024
sc Insider transactions 1 Nov 14, 2024
10-q Quarterly Reports 67 Nov 13, 2024
8-k 8K-related 15 Nov 13, 2024
upload Comment letters 2 Nov 12, 2024
corresp Comment letters 1 Nov 12, 2024
s-3 Registration statements 10 Nov 07, 2024
8-k 8K-related 13 Nov 07, 2024

Latest News


× Before browsing our site, please accept our cookies policy